-
公开(公告)号:US20080015216A1
公开(公告)日:2008-01-17
申请号:US11629449
申请日:2005-07-08
申请人: Sandro Belvedere , Joey Lee Methot , Thomas Miller , David Witter , Jiaming Yan
发明人: Sandro Belvedere , Joey Lee Methot , Thomas Miller , David Witter , Jiaming Yan
IPC分类号: A61K31/16 , A61K31/381 , A61K31/426 , A61K31/47 , A61P35/00 , C07C259/04 , C07D215/36 , C07D277/38 , C07D333/34
CPC分类号: C07C311/42 , C07C311/13 , C07C311/19 , C07C311/24 , C07C311/29 , C07D215/36 , C07D277/46 , C07D333/34 , C07D417/12
摘要: This invention relates to hydroxamic acid derivatives having a sulfonamide linkage, that are inhibitors of histone deacetylase (HDAC), and are useful in the prevention and/or treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases, and in the prevention and/or treatment of restenosis.
摘要翻译: 本发明涉及具有磺酰胺键的异羟肟酸衍生物,其是组蛋白脱乙酰酶(HDAC)的抑制剂,可用于预防和/或治疗细胞增殖性疾病,例如癌症,自身免疫性,过敏性和炎性疾病,疾病 中枢神经系统(CNS)如神经变性疾病,以及预防和/或治疗再狭窄。
-
公开(公告)号:US07534918B2
公开(公告)日:2009-05-19
申请号:US11629449
申请日:2005-07-08
IPC分类号: C07C259/04 , A61K31/19
CPC分类号: C07C311/42 , C07C311/13 , C07C311/19 , C07C311/24 , C07C311/29 , C07D215/36 , C07D277/46 , C07D333/34 , C07D417/12
摘要: This invention relates to hydroxamic acid derivatives having a sulfonamide linkage, that are inhibitors of histone deacetylase (HDAC), and are useful in the prevention and/or treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases, and in the prevention and/or treatment of restenosis.
摘要翻译: 本发明涉及具有磺酰胺键的异羟肟酸衍生物,其是组蛋白脱乙酰酶(HDAC)的抑制剂,可用于预防和/或治疗细胞增殖性疾病,例如癌症,自身免疫性,过敏性和炎性疾病,疾病 中枢神经系统(CNS)如神经变性疾病,以及预防和/或治疗再狭窄。
-